当前位置: 首页 > 期刊 > 《医学信息》 > 202017
编号:13844301
老年社区获得性肺炎诊治报道1例并文献复习(3)
http://www.100md.com 2020年4月30日 《医学信息》 202017
     [6]Lee JS,Giesler DL,Gellad WF,et al.Antibiotic Therapy for Adults Hospitalized WithCommunity-Acquired Pneumonia: A Systematic Review[J].JAMA,2016,315(6):593-602.

    [7]刘又宁,何礼贤.肺真菌病诊断和治疗专家共识[J].中华结核和呼吸杂志,2007,30(11):821-822.

    [8]Huttner B,Cappello B,Cooke G,et al.2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use[J].Am J Respir Crit Care Med,2020,201(10):1315-1316.

    [9]Costantini E,Allara E,Patrucco F,et al.Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality[J].Intern Emerg Med,2016(11):929-940.

    [10]Lipinska-Gediga M,Mierzchala M,Durek G.Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance[J].Infection,2012,40(3):303-309.

    [11]Self WH,Balk RA,Grijalva CG,et al.Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia[J].Clin Infect Dis,2017,65(2):183-190.

    [12]Kamat IS,Ramachandran V,Eswaran H,et al.Low procalcitonin, community acquired pneumonia, and antibiotic therapy[J].Lancet Infect Dis,2018(18):496-497.

    收稿日期:2020-06-16;修回日期:2020-07-02

    編辑/杜帆, 百拇医药(杨昌妮 李宇 李晓芳)
上一页1 2 3